Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities

C Hu, J Yang, Z Qi, H Wu, B Wang, F Zou, H Mei… - MedComm, 2022 - Wiley Online Library
The heat shock proteins (HSPs) are ubiquitous and conserved protein families in both
prokaryotic and eukaryotic organisms, and they maintain cellular proteostasis and protect …

Genetic animal models of Parkinson's disease

TM Dawson, HS Ko, VL Dawson - Neuron, 2010 - cell.com
Parkinson's disease (PD) is a progressive neurodegenerative disorder that is characterized
by the degeneration of dopamine (DA) and non-DA neurons, the almost uniform presence of …

DOPAL initiates αSynuclein-dependent impaired proteostasis and degeneration of neuronal projections in Parkinson's disease

A Masato, N Plotegher, F Terrin, M Sandre… - npj Parkinson's …, 2023 - nature.com
Dopamine dyshomeostasis has been acknowledged among the determinants of nigrostriatal
neuron degeneration in Parkinson's disease (PD). Several studies in experimental models …

PINK1 cleavage at position A103 by the mitochondrial protease PARL

E Deas, H Plun-Favreau, S Gandhi… - Human molecular …, 2011 - academic.oup.com
Mutations in PTEN-induced kinase 1 (PINK1) cause early onset autosomal recessive
Parkinson's disease (PD). PINK1 is a 63 kDa protein kinase, which exerts a neuroprotective …

The role of innate and adaptive immunity in Parkinson's disease

GT Kannarkat, JM Boss… - Journal of Parkinson's …, 2013 - content.iospress.com
In recent years, inflammation has become implicated as a major pathogenic factor in the
onset and progression of Parkinson's disease. Understanding the precise role for …

Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2

D Ramonet, JPL Daher, BM Lin, K Stafa, J Kim… - PloS one, 2011 - journals.plos.org
Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene cause late-onset, autosomal
dominant familial Parkinson's disease (PD) and also contribute to idiopathic PD. LRRK2 …

Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease-related mutant α-synuclein

X Lin, L Parisiadou, XL Gu, L Wang, H Shim, L Sun… - Neuron, 2009 - cell.com
Mutations in α-synuclein and Leucine-rich repeat kinase 2 (LRRK2) are linked to autosomal
dominant forms of Parkinson's disease (PD). However, little is known about any potential …

14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization

RJ Nichols, N Dzamko, NA Morrice… - Biochemical …, 2010 - portlandpress.com
LRRK2 (leucine-rich repeat protein kinase 2) is mutated in a significant number of
Parkinson's disease patients, but still little is understood about how it is regulated or …

LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model

J Alegre-Abarrategui, H Christian… - Human molecular …, 2009 - academic.oup.com
Leucine rich repeat kinase 2 (LRRK2) mutations are the most common genetic cause of
Parkinson's disease (PD) although LRRK2 function remains unclear. We report a new role …

Zebrafish as an animal model for drug discovery in Parkinson's disease and other movement disorders: a systematic review

RL Vaz, TF Outeiro, JJ Ferreira - Frontiers in neurology, 2018 - frontiersin.org
Movement disorders can be primarily divided into hypokinetic and hyperkinetic. Most of the
hypokinetic syndromes are associated with the neurodegenerative disorder Parkinson's …